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Abstract
Prolactin (PRL) stimulates lactogenesis in mammary cells and mitogenesis in a variety of cell types including Nb2 cells.
Studies indicate that a different composite of signaling pathways is involved in the PRL stimulation of mitogenesis as
compared to lactogenesis. In the present studies, PRL is shown to stimulate the tyrosyl phosphorylation of all three isoforms
of Shc proteins in Nb2 cells (mitogenesis), but not in the mammary gland. Maximal phosphorylation of the Shc proteins is
expressed between 10 and 15 min after a 50-ng/ml PRL treatment. In addition, there is an increased association between the
Grb2 protein and Shc proteins upon PRL stimulation. However, no increased association between JAK2 and Shc proteins
was observed in either the Nb2 cells or mammary tissues. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Prolactin (PRL) is a peptide hormone with a wide
range of functions including regulation of di¡erentia-
tive and developmental processes in the mammary
gland and certain male accessory sex glands, and
the regulation of speci¢c immune responses [1]. The
PRL receptor (PRLR) has three forms (long, inter-
mediate, and short), which di¡er primarily in the
length of their cytoplasmic domains [2]. These
PRLR isoforms belong to the cytokine/hematopoie-
tin receptor superfamily. This superfamily also in-
cludes receptors for growth hormone (GH) and a
variety of cytokine and growth factors [3,4]. Com-
parison of the amino acid sequences of the PRLR
and GHR reveals a linear arrangement of regions of
similar sequences [5], and both receptors are evolved
from a single gene localized in the same region of
human chromosome 5 [6]. They have structural and
functional similarities. It has also become apparent
that they recruit and/or activate many of the same
kinases and signaling proteins in their signal trans-
duction pathways. Some of the most common signal-
ing molecules involved in both systems include the
Janus kinase (JAK2) [7^11], the MAP kinases (MAP)
[12^15] and the Stat proteins (Stat 5) [16^19].
Shc proteins have been shown to be involved in
the GH signaling pathway [20,21]. Upon GH activa-
tion, Shc proteins are phosphorylated on tyrosyl res-
idues. The activated Shc acts as a linker protein and
binds to other signaling proteins via its SH2 (src
homology) domains, particularly to Grb2. However,
involvement in PRL-induced mitogenesis and lacto-
genesis has not heretofore been determined. In order
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to study the possible involvement of Shc proteins in
PRL-induced processes, two primary model systems
were employed: Nb2 cells in which the mitogenic
e¡ect of PRL is expressed, and the mouse mammary
gland explant system in which the lactogenic e¡ects
of PRL are expressed. The Nb2 cell line, the only cell
line known to express the intermediate form of the
PRLR [22], is dependent on lactogenic hormone
stimulation for continuous progression through the
cell cycle [23]. The goals of the present studies are
not only to examine the involvement of the Shc pro-
teins in PRL signal transductions in both Nb2 cells
and mouse mammary gland, but also to study the
possible relationship between the Shc proteins and
other proteins. Since the involvement of Shc in the
tyrosine kinase signaling pathways requires its phos-
phorylation, we isolated Shc proteins from Nb2 and
mouse mammary gland tissues to detect its tyrosyl
phosphorylation states. In further studies, we inves-
tigated the time and concentration e¡ects of PRL on
Shc protein phosphorylations.
2. Materials and methods
2.1. Nb2 cell preparation
Nb2 cells (provided by Dr. C.T. Beer) were grown
in 75-mm2 culture £asks containing Fisher’s medium
supplemented with 10% fetal calf serum, 10% horse
serum (Sigma, St. Louis, MO), 1U1034 M 2-mercap-
toethanol, 100 IU/ml penicillin, 100 Wg/ml streptomy-
cin (Eli Lilly, Indianapolis, IN), 7.5% NaHCO3, and
290 mg/ml glutamine. After cells have entered the log
growth stage they were collected by centrifugation at
200Ug. Cells were arrested at G0 by incubation for
24 h in 0% Fisher’s (Fisher’s having no HS and FCS)
at 500 000 cells/ml. The Nb2 cells were then collected
by centrifugation at 200Ug for 5 min and resus-
pended in fresh Fisher’s medium at 1 million cells/
ml. Cell aliquots were treated with di¡erent concen-
trations of oPRL (NIH-P-S-17, a gift from NIDDK)
for di¡erent times. Treated cell samples were then
collected by centrifugation. To individual samples
were added lysis bu¡er at 2^10U107 cells/ml accord-
ing to di¡erent experiments. The total lysates were
used for immunoprecipitation and Western blotting
assays.
2.2. Mouse mammary gland explant preparation
Twelve- to 14-day pregnant mice were killed by
cervical dislocation after which caudal and inguinal
pairs of mammary glands were removed and placed
in Hank’s balanced salt solution. The explants were
prepared as described by Rillema [24]. Glands were
cut into explants of approximately 3 mg each. Ex-
plants from 18 to 20 animals were randomly placed
in 60U15 mm culture dishes containing siliconized
lens paper £oating on 6 ml of M-199 medium. This
medium was supplemented with 1037 M cortisol and
1 Wg/ml insulin. Tissues were incubated for 24 h at
37‡C in an atmosphere of 95% O2^5% CO2. Then the
medium was changed with M-199 without any hor-
mone for 24 h. Ovine PRL at a concentration of
1 Wg/ml were added and tissues were cultured for
variable time periods. Tissues were homogenized in
2 times lysis bu¡er which contained 2% NP-40,
50 mM NaCl, 10 mM Tris, 30 mM Na2P2O7,
2.5 mM EDTA, 1 mM NaVO4, 1 mM PMSF,
10 Wg/ml aprotinin and 10 Wg/ml leupeptin, and
then centrifuged at 100 000Ug for 1 h at 4‡C. Solu-
ble proteins in lysis preparations were subject to im-
munoprecipitation and Western blotting assays.
2.3. Immunoprecipitation and immunoblotting
Nb2 cell or MMG lysates were immunoprecipi-
tated with anti-SHC polyclonal antibody (UBI #06-
203, 5 Wg/ml) at 4‡C overnight. SHC^antibody im-
munocomplexes were collected by incubation with 50
Wl anti-rabbit IgG agarose (Sigma, A-1027) for 4 h at
4‡C. Proteins were solubilized in 50 Wl SDS^Laemmli
sample bu¡er and heated 95‡C for 5 min. Samples
were separated by SDS^PAGE (8^20% linear gra-
dient) under reducing conditions and transferred to
PVDF membranes (Schleicher and Schuell). Mem-
branes were probed with anti-phosphotyrosine
(UBI, #05-321 50 ml at 1:1000), anti-SHC (UBI,
#06-203; 50 ml at 1:2000), anti-GRB2 (UBI, #05-
372; 20 ml at 1:1000) or anti-JAK2 (UBI, #06-255;
20 ml 1:2000) for 2 h. The secondary antibodies used
were anti-rabbit IgG^HRP conjugate (Amersham
NA 934; 1:3000 to 1:5000) or anti-mouse IgG
HRP conjugate (Amersham NA 931 at 1:5000) ac-
cording to di¡erent primary antibodies for 1.5 h.
Detection was accomplished by incubation with en-
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hanced chemiluminescence reagents (Amersham) and
exposure to X-ray ¢lm.
3. Results
In initial experiments, the time course of tyrosyl
phosphorylations of Shc proteins was determined.
Nb2 cells arrested in G0/G1 were incubated in the
absence or presence of PRL for di¡erent periods of
time. Cells were lysed and the Shc proteins were im-
munoprecipitated with anti-Shc antibody serum. The
isolated proteins were separated by SDS^PAGE and
transferred to PVDF membranes. The membranes
were probed with either anti-phosphotyrosine (Fig.
1) or anti-Shc (Fig. 2a) antibodies to examine the
degree of Shc tyrosyl phosphorylation in response
to PRL. As is shown in Fig. 1, three distinct tyrosyl
phosphorylated bands were apparent; these migrated
at 46, 52 and 66 kDa. These bands are consistent
with the molecular weights of the three isoforms of
the Shc proteins. They were phosphorylated rapidly
within 5 min, maximally phosphorylated between 10
and 15 min and then dephosphorylated. Fig. 2b
shows that there was also an association between
Shc and Grb2, since Grb2 was visualized when the
same membranes were immunoblotted with anti-
Grb2 antibody.
In further experiments, Shc protein phosphory-
lation was studied in Nb2 cells treated with increas-
Fig. 1. Time-course study of PRL-induced tyrosyl phosphory-
lation of Shc proteins in Nb2 cells. G1-arrested Nb2 cells
(1U108/ml) were incubated in the absence or presence of oPRL
(50 ng/ml) for the indicated time (min). Total lysate prepara-
tions were immunoprecipitated with anti-Shc polyclonal anti-
body. Isolated proteins were separated by 8^20% SDS^PAGE.
The transferred PVDF membrane was probed with anti-phos-
photyrosine antibody (top panel). The phosphorylations of Shc
proteins were quantitated using a scanning laser densitometer
(bottom panel). b, p66 band; P, p52 band; F, p46 band.
Fig. 2. Time course of Shc protein phosphorylations in response
to PRL. The same membrane used in Fig. 1 was stripped and
re-probed with anti-Shc (a) or anti-Grb2 (b) antibodies.
Fig. 3. E¡ect of PRL concentrations on tyrosyl phosphorylation
of the Shc protein. G1-arrested Nb2 cells (2U107/ml) were
treated with increasing concentrations of oPRL for 10 min. To-
tal lysate preparations were immunoprecipitated with anti-Shc
polyclonal antibody. Isolated proteins were separated by SDS^
PAGE. The transferred membrane was immunoblotted with
anti-phosphotyrosine (a) or anti-Shc (b) antibodies.
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ing PRL concentrations from 500 pg/ml to 2 Wg/ml.
As shown in Fig. 3, 50 ng/ml PRL signi¢cantly in-
creases phosphorylation of two Shc proteins (the 52-
and 66-kDa isoforms). Similar to earlier experiments,
PRL is also shown to stimulate JAK2 kinase activity.
In order to determine the e¡ect of PRL on phos-
phorylation and possible interaction of JAK2 and
Shc proteins, control or PRL-treated cell extracts
were immunoprecipitated with anti-JAK2 or anti-
Shc antibodies, and then immunoblotted with anti-
phosphotyrosine antibody. PRL increased both
JAK2 and Shc tyrosyl phosphorylations (Fig. 4). In
order to determine whether there is any association
between JAK2 and Shc proteins, the same mem-
branes were immunoblotted with both anti-JAK2
and anti-Shc antibodies. There was no detectable as-
sociation between JAK2 and Shc in PRL-treated
samples (Fig. 5).
In a subsequent series of experiments, the possible
involvement of Shc proteins in PRL signaling trans-
duction was investigated in mouse mammary gland
explants. The cultured mouse mammary gland tissues
were treated with or without PRL (1 Wg/ml) and total
tissue lysate was immunoprecipitated with anti-Shc
antibody. Isolated proteins were separated by SDS^
PAGE. Fig. 6 shows that there was no signi¢cant
tyrosyl phosphorylation in either control or PRL-
treated samples after immunoblotting with anti-phos-
photyrosine antibody. In order to con¢rm the exis-
tence of Shc proteins in these samples, a subsequent
probing of the same membrane was done with anti-
Shc antibodies. As predicted, the same amount of
Shc proteins were visualized in both control and
PRL-treated groups.
4. Discussion
As mentioned above, the roles of Janus kinase and
MAP kinases have been well studied in signaling
pathways of the cytokine/hematopoietin receptor
superfamily. It is well established that the Shc pro-
Fig. 4. E¡ect of PRL on tyrosyl phosphorylations of the JAK2
kinase and Shc protein in Nb2 cells. G1 arrested Nb2 cells
(2U107/ml) were incubated in the absence or presence of oPRL
(50 ng/ml) for 10 min. Total cell lysate preparations (TCL)
were immunoprecipitated with anti-JAK2 or anti-Shc antibod-
ies. Samples were separated by SDS^PAGE and transferred to
a PVDF membrane, which was probed with anti-phosphotyro-
sine antibody.
Fig. 5. The same membrane used in Fig. 4 was stripped and re-
probed with anti-JAK2 (a) or anti-Shc (b).
Fig. 6. Time-course of the e¡ect of PRL on Shc proteins in
mouse mammary gland tissues. The explants were cultured for
24 h with M-199 in the presence of 1 Wg/ml insulin and 1037 M
cortisol followed by another 24 h with M-199 without insulin
and cortisol. After pre-incubation, 1 Wg/ml PRL was added for
di¡erent periods of time and Shc proteins were immunoprecipi-
tated from total tissue lysate (TCL). The separated samples
were transferred to a PVDF membrane and probed with either
anti-phosphotyrosine (a) or anti-Shc (b) antibodies.
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teins play a role as an adapter protein in many of
these signaling pathways. However, the involvement
of the Shc protein in the PRL signaling pathway has
not been well studied.
The time-course experiments showed that an in-
creased tyrosyl phosphorylation level was observed
in the PRL-treated samples from Nb2 cells. In addi-
tion, all three isoforms of Shc proteins were
phosphorylated. In dose^response experiments, it
was found that 50 ng/ml PRL could maximally stim-
ulate tyrosyl phosphorylation of Shc proteins. How-
ever, compared with that of JAK2, the degree of
tyrosyl phosphorylation of Shc proteins in response
to PRL was less dramatic.
Although Shc is believed to be a substrate for
JAK2 in T47D cells, a human breast cancer cell
line [25], we were unable to detect the association
between JAK2 and Shc upon PRL stimulation in
Nb2 cells. These results raise the possibility that oth-
er proteins or adapter molecules might be involved in
mediating or enhancing the association of JAK2 with
Shc.
Although the involvement of Shc in the tyrosine
kinase signaling pathways appears to require its
phosphorylation in Nb2 cells, no signi¢cant tyrosyl
phosphorylation in either the control or PRL-treated
mouse mammary gland tissues was observed. Possi-
ble explanations for this phenomenon are: (1) the
concentration of Shc proteins in mouse mammary
gland tissues is very low; (2) the major functional
isoform of Shc proteins is di¡erent in Nb2 cells
from that in the mouse mammary gland; (3) full
activation of Shc proteins may require synergism
with other growth factors; or (4) Shc proteins may
not be involved in the lactogenic actions of PRL.
The latter possibility appears most plausible at
present.
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